Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof

Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof

US Patent 9724430 · Granted Aug 8, 2017

Estimated economic value: $26,388,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Composition for treatment of Crigler-Najjar syndrome2024
Modulating expression of polypeptides via new gene switch expression systems2024
Compositions comprising a lecithin cholesterol acyltransferase variant and uses 2024
AAV-ABCD1 constructs and use for treatment or prevention of adrenoleukodystrophy2023
Modulating expression of polypeptides via new gene switch expression systems2023
AAV-mediated expression of anti-influenza antibodies and methods of use thereof2022
Compositions and methods useful for prophylaxis of organophosphates2022
Composition for treatment of Crigler-Najjar syndrome2022
Compositions for treatment of wet age-related macular degeneration2021
Animal models for nonalcoholic fatty liver disease2021
Compositions comprising AAV expressing dual antibody constructs and uses thereof2021
AAV mediated influenza vaccines2020